DOUBLE‐BLIND COMPARISON OF MICONAZOLE/CORTICOSTEROID COMBINATION VERSUS MICONAZOLE IN INFLAMMATORY DERMATOMYCOSES
1995; Wiley; Volume: 34; Issue: 2 Linguagem: Italiano
10.1111/j.1365-4362.1995.tb03597.x
ISSN1365-4632
Autores Tópico(s)Antifungal resistance and susceptibility
ResumoInternational Journal of DermatologyVolume 34, Issue 2 p. 125-128 DOUBLE-BLIND COMPARISON OF MICONAZOLE/CORTICOSTEROID COMBINATION VERSUS MICONAZOLE IN INFLAMMATORY DERMATOMYCOSES SIEGFRIED NOLTING M.D., Corresponding Author SIEGFRIED NOLTING M.D. Department of Dermatology, Faculty of Medicine, University of Muenster, Muenster, Germany, and Hermal Research and Development, Reinbek/Hamburg, Germany.Address for correspondence: Siegfried Nolting, M.D., Hautklinik, Abt. Mikrobiologie, Universität, Munster, von-Esmarch-Strasse 56, D 48149 Munster, Germany.Search for more papers by this authorKONSTANTIN ROGALLA M.D., KONSTANTIN ROGALLA M.D. Department of Dermatology, Faculty of Medicine, University of Muenster, Muenster, Germany, and Hermal Research and Development, Reinbek/Hamburg, Germany.Search for more papers by this author SIEGFRIED NOLTING M.D., Corresponding Author SIEGFRIED NOLTING M.D. Department of Dermatology, Faculty of Medicine, University of Muenster, Muenster, Germany, and Hermal Research and Development, Reinbek/Hamburg, Germany.Address for correspondence: Siegfried Nolting, M.D., Hautklinik, Abt. Mikrobiologie, Universität, Munster, von-Esmarch-Strasse 56, D 48149 Munster, Germany.Search for more papers by this authorKONSTANTIN ROGALLA M.D., KONSTANTIN ROGALLA M.D. Department of Dermatology, Faculty of Medicine, University of Muenster, Muenster, Germany, and Hermal Research and Development, Reinbek/Hamburg, Germany.Search for more papers by this author First published: February 1995 https://doi.org/10.1111/j.1365-4362.1995.tb03597.xCitations: 8AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Cope J. Mode of action of miconazole on Candida albicans: effect on growth, viability and K+release, J Gen Microbiol. 1980; 119: 245–251. 2 Van den Bossche H, Willemsens G, Cools W, et al. Bio chemical effects of miconazole on fungi, Chem Biol Interact. 1978; 21: 59–78. 3 Shadomy S, Paxton L, Espinel-Ingroff A, Shadomy J. In vitro studies with miconazole and miconazole nitrate. J Antimicrob Chemother 1977; 3: 147–152. 4 Yamaguchi H, Hiratani T, Plempel M. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole. Arzneimit-telforschung 1983; 33: 546–551. 5 Sawyer PR, Brogden RN, Pinder RM, et al. Miconazole: a review of its antifungal activity and therapeutic efficacy. Drug 1975; 9: 406–423. 6 Van Cutsem JM, Thienpont D. Miconazole, a broad- spectrum antimycotic agent with antibacterial activity. Chemotherapy 1972; 17: 392–404. 7 Portillo F, Gancedo C. Mode of action of miconazole on yeasts: inhibition of mitochondrial ATPase. Eur J Biochem 1984; 143: 273–276. 8 Fromtling RA. Overview of medically important anti fungal azole derivatives. Clin Microbiol Rev 1988; 1: 187–217. 9 Van Cauteren H, Lampo A, Vandenberghe J, et al. Toxicological profile and safety evaluation of antifungal azole derivatives. Mycoses. 1989; 32(Suppl 1): 60–66. 10 Lücker P, Nowak H, Stüttgen J, Werner G. Penetrationskinetik eines Tritium-markierten 9α-Fluor–16- Methylen-Prednisolonesters nach epicutaner Applikation beim Menschen. Arzneimittelforschung 1968; 18: 27–29. 11 Garetts M. Controlled double-blind comparative trial with a fluprenylidene acetate cream and its base. Arch Dermatol Res 1975; 251: 165–168. 12 Mertens RLJ, Morias J, Vermhamme G. A double-blind study comparing Daktacort®, miconazol and hydrocortisone in inflammatory skin infections. Dermatologica 1976; 153: 228–235. 13 Bo wring ARW, Mackay D, Taylor FR. The treatment of napkin dermatitis: a double-blind comparison of two steroid-antibiotic combinations. Pharmatherapeutica 1984; 3: 613–617. 14 Carbone F. Combination of an antiinflammatory steroid, an antibacterial agent and an antifungal agent. Clin Trials J 1985; 22: 158–164. 15 Pazzaglia A. Clinical results obtained with a combination of an anti-inflammatory steroid, an antibacterial agent and an antifungal in dermatological outpatient practice, Int J Clin Pharm Ther Toxicol. 1985; 23: 367–372. 16 Smith EB, Breneman DL, Russell F, et al. Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis. J Am Acad Dermatol 1992; 26: 125–127. 17 Björnberg A, Tegner E. Treatment of tinea with miconazole and miconazole-hydrocortisone, Curr Ther Res. 1986; 40: 471–474. 18 Dominguez L. Clinical efficacy and safety of combination creams with anti-inflammatory/antifungal/antibacterial properties. Clin Trials J 1987; 24: 156–166. 19 White I, Blatchford N. The treatment of secondary bacterial infections in atopic eczema with miconazole plus hydrocortisone. Br J Clin Pract 1983; 37: 215–216. 20 Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988; 119: 189–198. 21 Nilsson EJ, Henning CG, Magnusson I. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992; 27: 28–34. 22 Raab W. Effects of local corticosteroids in skin infections. Dermatologica. 1976; 152(Suppl 1): 67–79. Citing Literature Volume34, Issue2February 1995Pages 125-128 ReferencesRelatedInformation
Referência(s)